ACSBG2
Basic information
Region (hg38): 19:6135247-6193094
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (92 variants)
- not_provided (6 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACSBG2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000030924.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 88 | 93 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 88 | 7 | 2 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACSBG2 | protein_coding | protein_coding | ENST00000586696 | 13 | 57855 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.08e-10 | 0.915 | 125324 | 2 | 422 | 125748 | 0.00169 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.220 | 351 | 363 | 0.968 | 0.0000189 | 4405 |
Missense in Polyphen | 129 | 139.08 | 0.92754 | 1730 | ||
Synonymous | -1.02 | 155 | 140 | 1.11 | 0.00000825 | 1239 |
Loss of Function | 1.94 | 21 | 33.0 | 0.636 | 0.00000170 | 383 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0155 | 0.0154 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000772 | 0.000761 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000493 | 0.000484 |
Middle Eastern | 0.000772 | 0.000761 |
South Asian | 0.00268 | 0.00265 |
Other | 0.00131 | 0.00130 |
dbNSFP
Source:
- Function
- FUNCTION: Mediates activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Able to activate long-chain fatty acids. Also able to activate very long-chain fatty acids; however, the relevance of such activity is unclear in vivo. Has increased ability to activate oleic and linoleic acid. May play a role in spermatogenesis.;
- Pathway
- Adipocytokine signaling pathway - Homo sapiens (human);Fatty acid degradation - Homo sapiens (human);Fatty acid biosynthesis - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);PPAR signaling pathway;stearate biosynthesis;Metabolism of lipids;Fatty acyl-CoA biosynthesis;fatty acid activation;Metabolism;Fatty acid metabolism;γ-linolenate biosynthesis;fatty acid β-oxidation (peroxisome);fatty acid β-oxidation;Synthesis of very long-chain fatty acyl-CoAs
(Consensus)
Recessive Scores
- pRec
- 0.0908
Intolerance Scores
- loftool
- 0.950
- rvis_EVS
- 1.72
- rvis_percentile_EVS
- 96.48
Haploinsufficiency Scores
- pHI
- 0.126
- hipred
- N
- hipred_score
- 0.173
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.414
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acsbg2
- Phenotype
- skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype;
Gene ontology
- Biological process
- long-chain fatty acid metabolic process;fatty acid metabolic process;multicellular organism development;spermatogenesis;cell differentiation;long-chain fatty-acyl-CoA biosynthetic process
- Cellular component
- cytoplasm;mitochondrion;cytosol;membrane
- Molecular function
- long-chain fatty acid-CoA ligase activity;ATP binding;very long-chain fatty acid-CoA ligase activity;acyl-CoA hydrolase activity;decanoate-CoA ligase activity